| Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats. | |
| | |
MedLine Citation:
|
PMID: 22471901 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
It has been demonstrated that the antihypertensive drugs with the antioxidant action on the brainstem inhibit the sympathetic activity and consequently decrease blood pressure and heart rate (HR) in hypertensive rats. Combination drugs of the angiotensin receptor blocker and calcium channel blocker, such as olmesartan (OLM)/azelnidipine (AZ) and candesartan (CAN)/amlodipine (AM), are widely used for treating hypertension in Japan. In this study, it was investigated whether there are differences in the antioxidant effect in the brain and the sympathoinhibitory effect between OLM/AZ and CAN/AM combination therapies in stroke-prone spontaneously hypertensive rats (SHRSP). OLM/AZ (10/8 mg kg(-1) day(-1)), CAN/AM (4/2.5 mg kg(-1) day(-1)), or vehicle was orally administered for 30 days to SHRSP. OLM/AZ and CAN/AM markedly decreased systolic blood pressure to the same extent. OLM/AZ decreased HR to a greater extent than CAN/AM. Urinary norepinephrine excretion as a marker of sympathetic activity was unchanged in the CAN/AM group, but reduced in the OLM/AZ group. Oxidative stress in the whole brain assessed using the in vivo electron spin resonance method was similarly decreased in both OLM/AZ and CAN/AM groups. Importantly, thiobarbituric acid reactive substance levels in the brainstem were significantly lower in the OLM/AZ group, but not in the CAN/AM group, than in the vehicle group. These results suggest that combination therapy of either OLM/AZ or CAN/AM does not induce reflex-mediated sympathetic activation despite the marked blood pressure reduction, which is associated with an antioxidant effect in the brain regions affecting the sympathetic activity. Furthermore, the antioxidant effect in the brainstem and the sympathoinhibitory effect of OLM/AZ combination may be greater than those of CAN/AM combination treatment. |
| | |
Authors:
|
Keisuke Shinohara; Yoshitaka Hirooka; Kiyohiro Ogawa; Takuya Kishi; Keiji Yasukawa; Hideo Utsumi; Kenji Sunagawa |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-04-03 |
Journal Detail:
|
Title: Clinical and experimental hypertension (New York, N.Y. : 1993) Volume: 34 ISSN: 1525-6006 ISO Abbreviation: Clin. Exp. Hypertens. Publication Date: 2012 |
Date Detail:
|
Created Date: 2012-09-07 Completed Date: 2013-03-28 Revised Date: 2013-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 9305929 Medline TA: Clin Exp Hypertens Country: England |
Other Details:
|
Languages: eng Pagination: 456-62 Citation Subset: IM |
Affiliation:
|
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antihypertensive Agents / therapeutic use* Azetidinecarboxylic Acid / analogs & derivatives*, therapeutic use Benzimidazoles / therapeutic use Blood Pressure / drug effects* Brain / drug effects Calcium Channel Blockers / therapeutic use* Dihydropyridines / therapeutic use* Disease Models, Animal Drug Therapy, Combination Hypertension / drug therapy* Imidazoles / therapeutic use* Male Oxidative Stress / drug effects* Rats Rats, Inbred SHR Tetrazoles / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Benzimidazoles; 0/Calcium Channel Blockers; 0/Dihydropyridines; 0/Imidazoles; 0/Tetrazoles; 144689-24-7/olmesartan medoxomil; 2517-04-6/Azetidinecarboxylic Acid; PV23P19YUG/azelnidipine; S8Q36MD2XX/candesartan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Frequent Additional Tachyarrhythmias in Patients with Inappropriate Sinus Tachycardia Undergoing Sin...
Next Document: The use of regional platforms for managing electronic health records for the production of regional ...